These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11035060)

  • 1. Supra-agonist peptides enhance the reactivation of memory CTL responses.
    Micheletti F; Canella A; Vertuani S; Marastoni M; Tosi L; Volinia S; Traniello S; Gavioli R
    J Immunol; 2000 Oct; 165(8):4264-71. PubMed ID: 11035060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single specific amino acid residue in peptide antigens is sufficient to activate memory CTL: potential role of cross-reactive peptides in memory T cell maintenance.
    Reali E; Guerrini R; Marastoni M; Tomatis R; Masucci MG; Traniello S; Gavioli R
    J Immunol; 1999 Jan; 162(1):106-13. PubMed ID: 9886375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes.
    Khanna R; Burrows SR; Nicholls J; Poulsen LM
    Eur J Immunol; 1998 Feb; 28(2):451-8. PubMed ID: 9521052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
    Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxic T lymphocytes.
    Reali E; Guerrini R; Moretti S; Spisani S; Lanza F; Tomatis R; Traniello S; Gavioli R
    J Leukoc Biol; 1996 Aug; 60(2):207-13. PubMed ID: 8773582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in an HER-2 peptide upregulating HLA-A2 expression affect both conformational epitopes and CTL recognition: implications for optimization of antigen presentation and tumor-specific CTL induction.
    Fisk B; Savary C; Hudson JM; O'Brian CA; Murray JL; Wharton JT; Ioannides CG
    J Immunother Emphasis Tumor Immunol; 1995 Nov; 18(4):197-209. PubMed ID: 8680648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a human agonist cytotoxic T-lymphocyte epitope of human prostate-specific antigen.
    Terasawa H; Tsang KY; Gulley J; Arlen P; Schlom J
    Clin Cancer Res; 2002 Jan; 8(1):41-53. PubMed ID: 11801539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
    Zaremba S; Barzaga E; Zhu M; Soares N; Tsang KY; Schlom J
    Cancer Res; 1997 Oct; 57(20):4570-7. PubMed ID: 9377571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of direct alloreactivity of an HLA-B27-specific CTL clone by altered peptide ligands of its natural epitope.
    García-Peydró M; Paradela A; Albar JP; Castro JA
    J Immunol; 2000 Nov; 165(10):5680-5. PubMed ID: 11067925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides.
    Reali E; Guerrini R; Giori B; Borghi M; Marastoni M; Tomatis R; Traniello S; Masucci MG; Gavioli R
    Clin Exp Immunol; 1996 Aug; 105(2):369-75. PubMed ID: 8706347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist peptide from a cytotoxic t-lymphocyte epitope of human carcinoembryonic antigen stimulates production of tc1-type cytokines and increases tyrosine phosphorylation more efficiently than cognate peptide.
    Salazar E; Zaremba S; Arlen PM; Tsang KY; Schlom J
    Int J Cancer; 2000 Mar; 85(6):829-38. PubMed ID: 10709104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
    Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
    Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A partially agonistic peptide acts as a selective inducer of apoptosis in CD8+ CTLs.
    Wei CH; Beeson C; Masucci MG; Levitsky V
    J Immunol; 1999 Sep; 163(5):2601-9. PubMed ID: 10452999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures.
    Hausmann S; Biddison WE; Smith KJ; Ding YH; Garboczi DN; Utz U; Wiley DC; Wucherpfennig KW
    J Immunol; 1999 May; 162(9):5389-97. PubMed ID: 10228016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide.
    Correale P; Walmsley K; Zaremba S; Zhu M; Schlom J; Tsang KY
    J Immunol; 1998 Sep; 161(6):3186-94. PubMed ID: 9743387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines.
    Crotzer VL; Christian RE; Brooks JM; Shabanowitz J; Settlage RE; Marto JA; White FM; Rickinson AB; Hunt DF; Engelhard VH
    J Immunol; 2000 Jun; 164(12):6120-9. PubMed ID: 10843661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus.
    Solache A; Morgan CL; Dodi AI; Morte C; Scott I; Baboonian C; Zal B; Goldman J; Grundy JE; Madrigal JA
    J Immunol; 1999 Nov; 163(10):5512-8. PubMed ID: 10553078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: biological validation of the proposed HLA A24 supertype.
    Burrows SR; Elkington RA; Miles JJ; Green KJ; Walker S; Haryana SM; Moss DJ; Dunckley H; Burrows JM; Khanna R
    J Immunol; 2003 Aug; 171(3):1407-12. PubMed ID: 12874232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective amino acid substitutions of a subdominant Epstein-Barr virus LMP2-derived epitope increase HLA/peptide complex stability and immunogenicity: implications for immunotherapy of Epstein-Barr virus-associated malignancies.
    Micheletti F; Guerrini R; Formentin A; Canella A; Marastoni M; Bazzaro M; Tomatis R; Traniello S; Gavioli R
    Eur J Immunol; 1999 Aug; 29(8):2579-89. PubMed ID: 10458773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-phase epitope recovery: a high throughput method for antigen identification and epitope optimization.
    Lawendowski CA; Giurleo GM; Huang YY; Franklin GJ; Kaplan JM; Roberts BL; Nicolette CA
    J Immunol; 2002 Sep; 169(5):2414-21. PubMed ID: 12193709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.